185 related articles for article (PubMed ID: 20711816)
21. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Mato S; Alberdi E; Ledent C; Watanabe M; Matute C
Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.
Köfalvi A; Lemos C; Martín-Moreno AM; Pinheiro BS; García-García L; Pozo MA; Valério-Fernandes Â; Beleza RO; Agostinho P; Rodrigues RJ; Pasquaré SJ; Cunha RA; de Ceballos ML
Neuropharmacology; 2016 Nov; 110(Pt A):519-529. PubMed ID: 26976670
[TBL] [Abstract][Full Text] [Related]
23. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
24. The differential contractile responses to capsaicin and anandamide in muscle strips isolated from the rat urinary bladder.
Saitoh C; Kitada C; Uchida W; Chancellor MB; de Groat WC; Yoshimura N
Eur J Pharmacol; 2007 Sep; 570(1-3):182-7. PubMed ID: 17586490
[TBL] [Abstract][Full Text] [Related]
25. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro.
Kim SR; Lee DY; Chung ES; Oh UT; Kim SU; Jin BK
J Neurosci; 2005 Jan; 25(3):662-71. PubMed ID: 15659603
[TBL] [Abstract][Full Text] [Related]
26. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat.
Hong S; Fan J; Kemmerer ES; Evans S; Li Y; Wiley JW
Gut; 2009 Feb; 58(2):202-10. PubMed ID: 18936104
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
28. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
[TBL] [Abstract][Full Text] [Related]
29. Inhibition by anandamide and synthetic cannabimimetics of the release of [3H]D-aspartate and [3H]GABA from synaptosomes isolated from the rat hippocampus.
D'Amico M; Cannizzaro C; Preziosi P; Martire M
Neurochem Res; 2004 Aug; 29(8):1553-61. PubMed ID: 15260134
[TBL] [Abstract][Full Text] [Related]
30. Functional CB2 type cannabinoid receptors at CNS synapses.
Morgan NH; Stanford IM; Woodhall GL
Neuropharmacology; 2009 Sep; 57(4):356-68. PubMed ID: 19616018
[TBL] [Abstract][Full Text] [Related]
31. Distribution and function of the endocannabinoid system in the rat and human bladder.
Bakali E; Elliott RA; Taylor AH; Willets J; Konje JC; Tincello DG
Int Urogynecol J; 2013 May; 24(5):855-63. PubMed ID: 23081739
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
Shivachar AC
Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
[TBL] [Abstract][Full Text] [Related]
33. Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition.
Liao HT; Lee HJ; Ho YC; Chiou LC
Br J Pharmacol; 2011 May; 163(2):330-45. PubMed ID: 21232043
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action.
Köfalvi A; Vizi ES; Ledent C; Sperlágh B
Eur J Neurosci; 2003 Oct; 18(7):1973-8. PubMed ID: 14622229
[TBL] [Abstract][Full Text] [Related]
36. The endogenous cannabinoid anandamide inhibits transient receptor potential vanilloid type 1 receptor-mediated currents in rat cultured primary sensory neurons.
Sántha P; Jenes A; Somogyi C; Nagy I
Acta Physiol Hung; 2010 Jun; 97(2):149-58. PubMed ID: 20511124
[TBL] [Abstract][Full Text] [Related]
37. Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts.
Wagner JA; Abesser M; Karcher J; Laser M; Kunos G
J Cardiovasc Pharmacol; 2005 Sep; 46(3):348-55. PubMed ID: 16116341
[TBL] [Abstract][Full Text] [Related]
38. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
Aly E; Masocha W
IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
